Albert Bourla, Pfizer CEO (Evan Vucci, AP Images)
March 11, 2022 10:29 AM EST
Coronavirus

Covid-19 roundup: Pfiz­er read­ies FDA ap­pli­ca­tion for fourth dose to deal with Omi­cron

Zachary Brennan

Senior Editor

As hos­pi­tal­iza­tions be­gin to rise again in the UK, Pfiz­er CEO Al­bert Bourla told CN­BC yes­ter­day that the com­pa­ny will soon …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times